MLH1 p.Arg265Gly
Variant summary
The NM_000249.4(MLH1):c.793C>G (p.Arg265Gly) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.28). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV002676419: Wanat JJ et al. Hum. Mol. Genet. 2007 Feb;16:445-52" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars)
Frequency
Consequence
NM_000249.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 18 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV002676419: Wanat JJ et al. Hum. Mol. Genet. 2007 Feb;16:445-52; Drost M et al. Hum. Mutat. 2010 Mar;31:247-53; van der Klift HM et al. Mol Genet Genomic Med. 2015 Jul;3:327-45; Soukarieh O et al. PLoS Genet. 2016 Jan;12:e1005756.; SCV003786423: Studies have shown that this missense change results in skipping of exon 10, and produces a non-functional protein and/or introduces a premature termination codon (internal data).; SCV004185539: Functional studies indicate this variant impacts protein function [Myriad internal data].; SCV001363159: Internal RNA analysis reports experimental evidence that this variant affects mRNA splicing resulting in skipping of exon 10 and exon 10-11 in a smaller proportion of transcripts, each of which would result in an out-of frame outcome (internal data). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 4 pathogenic, 3 benign (OR vs. background: 6.4). | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.000636) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star); Other variants at the same amino acid residue (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Strong). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | MANE Select | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 19 | Prot: NP_000240.1 UniProt: | |
MLH1 | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 18 | Prot: NP_001341557.1 UniProt: | ||
MLH1 | c.694C>G p.Arg232Gly | missensesplice_region | Exon 9 of 18 | Prot: NP_001341558.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | TSL:1MANE Select | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 19 | Prot: ENSP00000231790.3 UniProt: | |
MLH1 | TSL:1 | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 17 | Prot: ENSP00000416687.3 UniProt: | |
MLH1 | TSL:1 | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 15 | Prot: ENSP00000416476.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 34 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.59 | |
CADD | Pathogenic | 31 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.90 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 1.0 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.7 | |
GPN-Star score | N/A | 9.7 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.79 | D |
MetaRNN | Pathogenic | 0.96 | D |
MetaSVM | Pathogenic | 0.94 | D |
Mutation Taster | N/A | 0/100 | disease causing |
MutationAssessor | Pathogenic | 4.8 | H |
PhyloP100 | Uncertain | 7.3 | |
popEVE | Benign | -4.1 | |
PrimateAI | Uncertain | 0.65 | T |
PROVEAN | Pathogenic | -7.0 | D |
REVEL | Pathogenic | 0.96 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.99 | |
VESM-3B | Benign | -15 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Uncertain | 0.31 | |
Pangolin loss | Uncertain | 0.31 | Position offset: -2 |
SpliceAI score (max) | Benign | 0.16 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.